循证中医药发展助推新发突发传染病临床研究能力提升

Evidence-based Chinese medicine promotes clinical research capacity for emerging infectious diseases

中医药循证医学研究取得了许多重要成就,推动了中医药现代化和国际化进程。而在新发突发传染病来袭之际,能否在应急救治状态下拿出指导临床实践的研究证据,是对循证中医药发展的重大考验。在循证中医药发展的过程中,历经了非典型性肺炎(SARS)、甲型HIN1流感、新型冠状病毒肺炎(COVID-19)等新发突发传染病事件,中医药研究人员在应急救治工作中开展临床研究的能力不断提升。本文对既往中医药抗击新发突发传染病中的临床研究情况进行概述,重点分析当下COVID-19救治所获得的临床研究成果,讨论在新发突发传染病蔓延态势下,循证中医药的发展对中医药临床研究能力的提升作用。

Evidence-based research in traditional Chinese medicine(TCM)has made many important achievements and promoted the modernization and internationalization of TCM.The ability to produce research evidence to guide clinical practice in an emergency treatment situation is a major test of the development of evidence-based Chinese medicine(EBCM)when emerging infectious diseases outbreaks.Along with the development of EBCM,TCM has experienced emerging infectious disease events such as atypical pneumonia(SARS),influenza A(HIN1),and corona virus disease 2019(COVID-19),and the ability of TCM to conduct clinical research in emergency treatment work has been continuously improved.This article provides an overview of the clinical research conducted in TCM to resist emerging infectious diseases in the past,focusing on the clinical research results obtained in the present time of COVID-19 rescue and treatment,and discusses the role of EBCM development to enhance the clinical research capacity of TCM in emerging infectious diseases.